Vincent Morgus, a former executive at life sciences services firm Quintiles, is the new chief financial officer at Cornerstone Therapeutics (Nasdaq: CRTX).

Cornerstone focuses on respiratory drugs.

At Quintiles, Morgus was senior vice president for corporate development since 2003. He joined the company in 1994. He earned an MBA at UNC-CH’s Kenan-Flager Business School.

Get the latest news alerts: Follow WRAL Tech Wire at Twitter.